Neoadjuvant chemotherapy: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | |||
==Overview== | ==Overview== | ||
'''Neoadjuvant chemotherapy''' refers to [[drug]] treatment given to people with [[cancer]] prior to surgery. The aim is to reduce the size of the cancer before surgery, thus making surgery easier and more likely to be successful. | '''Neoadjuvant chemotherapy''' refers to [[drug]] treatment given to people with [[cancer]] prior to surgery. The aim is to reduce the size of the cancer before surgery, thus making surgery easier and more likely to be successful. | ||
| Line 9: | Line 8: | ||
[[Adjuvant chemotherapy]] | [[Adjuvant chemotherapy]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 18:53, 26 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Neoadjuvant chemotherapy refers to drug treatment given to people with cancer prior to surgery. The aim is to reduce the size of the cancer before surgery, thus making surgery easier and more likely to be successful.